CA-PANASONIC-CORPORATION
29.1.2020 07:13:08 CET | Business Wire | Press release
On January 29, 2020, Panasonic Corporation announced it has succeeded in demonstrating the world's highest brightness blue laser. This has been achieved by using the wavelength beam combining (WBC) technology [1] on a direct diode laser (DDL) to produce a high quality output beam [2]. With this technology, power scaling is enabled while maintaining the beam quality by simply increasing the number of laser sources. This demonstration opens the door to laser intensities that could be two orders of magnitude higher than conventional blue laser systems. This technology will contribute to the emerging microfabrication processes, whose demand is expected to grow in industrial applications, such as in the automotive industry.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200128005907/en/
The automotive industry is moving towards “electrification” and “miniaturization” while requiring “high rigidity,” “design flexibility” and “productivity.” Against this background, the anticipation for the microfabrication lasers that can process various kinds of materials such as copper, gold and plastic is building up. Especially, blue laser with a high optical absorption efficiency has a high demand in the field of copper fabrication for the automotive motors and batteries. Highly-productive processing requires a laser beam source that has both high output power and high beam quality.
In order to attain such a beam source, Panasonic started collaboration with TeraDiode, Inc. (TDI), a Massachusetts, U.S.-based company, in 2013, and since has been developing WBC technology which can combine multiple and different wavelengths into one combined beam. In 2014, Panasonic released LAPRISS ; the world’s first laser welding robot system equipped with an infrared DDL using WBC technology*1 . In 2017, the company acquired TDI as a wholly owned subsidiary*2 and started developing on the output-power optimization on WBC as well as shortening the wavelength.
The output power optimization of the high-beam-quality blue laser (wavelength band = 400 – 450nm) was realized by combining more than 100 emitters from multiple diode bars [3] with WBC technology.
This WBC technology combines the beams from multiple emitters at different wavelengths that are incident on the diffraction grating at angles corresponding to each wavelength. The resonator is then formed in between the shared partially-transparent mirror and each edge face of the emitters. As a result, the output beam has achieved a output of 135 W with a high beam quality of BPP [4] 1.5mm・mrad.
Going forward, Panasonic will develop a processing system that is equipped with this laser beam source, as well as the process optimization in laser processing.
Panasonic will hold exhibits and lecture sessions on our technical achievement at PHOTONICS WEST 2020 in San Francisco from February 1 to 6, 2020.*3
A part of this research and development includes the data obtained from a project – “Development of advanced laser processing with intelligence based on high-brightness and high-efficiency laser technologies (TACMI project)” – commissioned by the New Energy and Industrial Technology Development Organization (NEDO) of Japan.
[Applications] Laser processing (welding, cutting, etc.)
[Patents] Total of 571 patents both domestic and international (including pending applications)
Notes:
*1: Panasonic Corporation Topics
April 15th
, 2014: Panasonic has Released a Laser Welding Robot System "LAPRISS"-Equipped with the world's first high-power direct diode laser
https://news.panasonic.com/jp/topics/2014/38440.html
(In Japanese)
*2: Panasonic Corporation News Release
January 6th
, 2017: Panasonic Acquires All Shares of U.S.-Based Industrial Laser Start-up TeraDiode, Inc.
https://news.panasonic.com/global/press/data/2017/01/en170106-3/en170106-3.html
*3: PHOTONICS WEST 2020, San Francisco, 1-6 February 2020
Glossary
[1] Wavelength Beam Combining (WBC) technology: The technology that combines the beams with different wavelengths that are emitted from the multiple DDLs (direct diode lasers) on a diffraction grating.
[2] Beam quality: An index indicates how easy it is to combine the beam. Higher beam quality has smaller diameter and highly collimate feature.
[3] Diode bar: A laser bar that has multiple emittance stripes (emitters) in an array configuration on a single semiconductor chip.
[4] BPP (Beam Parameter Products): This is defined as the product of the radius r0 of the beam waist at the focusing position multiplied by the half-value half-width θ of the beam divergence angle; BPP = r0xθ. The unit is expressed in [mm・mrad]. The smaller BPP is, the higher the beam quality becomes.
About Panasonic
Panasonic Corporation is a worldwide leader in the development of diverse electronics technologies and solutions for customers in the consumer electronics, housing, automotive, and B2B businesses. The company, which celebrated its 100th
anniversary in 2018, has expanded globally and now operates 582 subsidiaries and 87 associated companies worldwide, recording consolidated net sales of 8.003 trillion yen for the year ended March 31, 2019. Committed to pursuing new value through innovation across divisional lines, the company uses its technologies to create a better life and a better world for its customers. To learn more about Panasonic: https://www.panasonic.com/global
.
Source: https://news.panasonic.com/global/press/data/2020/01/en200129-2/en200129-2.html
Related Links
Industrial Devices & Solutions - Panasonic
https://industrial.panasonic.com/ww
TeraDiode, Inc.
https://www.teradiode.com/
View source version on businesswire.com: https://www.businesswire.com/news/home/20200128005907/en/
Link:
Social Media:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Incyte Announces New Positive 54-Week Late-Breaking Data for Povorcitinib in Hidradenitis Suppurativa at the 2026 American Academy of Dermatology (AAD) Annual Meeting28.3.2026 20:00:00 CET | Press release
Phase 3 data from the STOP-HS program demonstrate povorcitinib’s substantial and durable clinical efficacy through Week 54 in patients with moderate to severe hidradenitis suppurativa (HS). Through Week 54, clinically meaningful and durable responses were observed across all groups in both STOP-HS1 and STOP-HS2, with up to 71.4% of patients achieving HiSCR50. Improvements in clinical responses across high stringent thresholds were observed, with up to 57% of participants achieving HiSCR75 and up to 29% of participants achieving HiSCR100. Povorcitinib treatment led to consistent reductions across key inflammatory lesion types, with full resolution (ANdT=0) achieved in up to 20% of patients. Additionally, clinically meaningful improvements in quality-of-life measures, including skin pain and fatigue, were observed at Week 54. The overall safety profile of povorcitinib through 54 weeks is consistent with previously reported data, and both doses were well tolerated. Incyte (Nasdaq:INCY) to
Takeda’s Zasocitinib Delivered Rapid and Durable Skin Clearance in a Convenient Once-Daily Pill, Affirming Promise to Reshape Psoriasis Care28.3.2026 20:00:00 CET | Press release
About 70% of patients treated with zasocitinib achieved clear or almost clear skin (sPGA 0/1) at week 16 in Phase 3 plaque psoriasis studies A significantly greater PASI 75 response rate versus placebo was observed as early as week 4 Safety profile consistent with Phase 2b studies with no new safety signals identified Takeda(TSE:4502/NYSE:TAK)today announced new data from the two pivotal Phase 3studies of zasocitinib (TAK-279), a next-generation, highly selective oral tyrosine kinase 2 (TYK2) inhibitor, in adults with moderate-to-severe plaque psoriasis (PsO).1 Presented as a late-breaking abstract at the 2026 American Academy of Dermatology (AAD) Annual Meeting, these data show that convenient once-daily oral zasocitinib demonstrated rapid and durable skin clearance with a safety profile consistent with Phase 2b studies.1,2 “Our goal in psoriasis treatment is clear or almost clear skin, and previously this has been achieved primarily with injectable therapies,” said Melinda Gooderham,
AAD 2026: Late-Breaking Nemolizumab Data Demonstrate Clinically Meaningful Benefits for Children Aged 2 to 11 With Moderate-to-Severe Atopic Dermatitis28.3.2026 16:00:00 CET | Press release
Pharmacokinetics, safety and efficacy clinical study data show that nemolizumab achieved clinically meaningful reductions in skin lesions and itch through Week 16, which were sustained up to a year in children aged 2 to 11 with moderate-to-severe atopic dermatitis1 These findings reinforce the previously established safety and efficacy of nemolizumab in adults and adolescents with moderate-to-severe atopic dermatitis, for which it is approved by multiple global regulatory authorities2,3 Up to 25% of children are affected by atopic dermatitis, and currently there are limited approved treatment options for children living with moderate-to-severe atopic dermatitis4,5 Galderma (SIX: GALD) today announced new phase II data showing that nemolizumab was well tolerated and effective in children (aged 2 to 11 years) with moderate-to-severe atopic dermatitis, with a clinically meaningful and sustained reduction in skin lesions and itch for up to a year.1 Results will be presented in a late-break
Angelalign Technology (6699.HK)Releases 2025 Results: Passion for Clinical Excellence Drives Worldwide Growth27.3.2026 20:56:00 CET | Press release
Angelalign Technology Inc. (6699.HK) (“Angel” or the “Company”) released its financial results for fiscal year 2025. During the reporting period, the Company continued to do well in both the global and China markets. Total case volume was 532,400, which increased 48.1%, revenue was USD 370.3 million, which increased 37.8%, and adjusted net profit was USD 43.8 million, which increased 63.0%. The results were driven by Angel’s passion for clinical excellence and its open and inclusive culture that empowers talented people to work together to meet customer needs, the Company said. Fox Hu, CEO of Angel, stated: “The clear aligner industry is complex and multidisciplinary. It requires top-tier technical and operational talent along with seamless collaboration among professionals from diverse geographies. Angel’s open and inclusive culture attracts professionals who share a passion for clinical excellence and a dedication to bringing outstanding products and services to customers. This melti
Axway Positioned as a Leader in the IDC MarketScape: Worldwide API Management 2026 Vendor Assessment27.3.2026 18:46:00 CET | Press release
Axway, a 74Software company (Euronext: 74SW) and global leader in federated API management and enterprise integration, has been named a Leader in the IDC MarketScape: Worldwide API Management 2026 Vendor Assessment.1 Axway Amplify securely connects, orchestrates, and automates data integration. Organizations in financial services, manufacturing, healthcare, and other industries rely on Amplify to modernize integrations and confidently unlock data to deliver superior digital services faster. The report notes: “The platform benefits from Axway’s long-standing experience in B2B integration, secure file transfer, and legacy connectivity, providing differentiated capabilities for organizations that need to expose and control APIs around core systems that are not cloud-native.”1 This multi-pattern expertise in security, integration, and federated governance — built during the early phases of the API-driven digital transformation — becomes especially critical as enterprises seek to govern dat
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom